PT-141 vs Addyi: Key Differences & Which to Consider | telos rx
Smiling couple embracing outdoors, illustrating PT-141 vs Addyi for low sexual desire
← Back to blog
bremelanotide

PT-141 vs Addyi: Differences, Risks & Which to Consider

By TelosRX Editorial Team

PT-141 vs Addyi comes down to timing and pathway. PT-141 (bremelanotide) is an as-needed injection acting on melanocortin receptors. Addyi (flibanserin) is a daily bedtime pill acting on serotonin. TelosRX compares both, side by side.

Low sexual desire gets far less airtime than erectile dysfunction. Yet it's common, and it can be genuinely distressing.

Two prescription medications are FDA-approved for a specific form of it in women: Vyleesi, the brand version of PT-141, and Addyi. They're often lumped together as "female Viagra." That label is wrong for both.

Below, we compare PT-141 vs Addyi on mechanism of action, dosing, side effects of Addyi and PT-141, alcohol rules and evidence. Then we cover who tends to consider which.

PT-141 vs Addyi: The Short Version

  • PT-141 is a peptide. You use it only when you plan to be intimate, about 45 minutes beforehand.
  • Addyi is a pill. You take it every night at bedtime, whether or not you plan sex.
  • Both act on the brain, not on blood flow. Neither works like Viagra.
  • FDA approval covers premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) for the brand products only.

Compounded PT-141 is a different matter. It is not FDA-approved, even though it shares an active ingredient with Vyleesi.

Head-to-Head Comparison Table

Factor PT-141 (bremelanotide / Vyleesi) Addyi (flibanserin)
Drug type Synthetic peptide Small-molecule tablet
Main target Melanocortin receptors, mainly MC4R Serotonin receptors (5-HT1A and 5-HT2A)
How it's taken Under-the-skin injection Oral pill
Timing As needed, about 45 minutes before activity Every day at bedtime
Dose limits (brand label) 1.75 mg; no more than 1 dose in 24 hours or 8 per month 100 mg once daily
FDA approval (brand) Vyleesi, 2019 Addyi, 2015
Approved population Premenopausal women with acquired, generalized HSDD Premenopausal women with acquired, generalized HSDD
Most common side effects Nausea, flushing, headache, injection-site reactions Dizziness, sleepiness, nausea, fatigue
Alcohol No specific alcohol restriction on the label Timing rules; serious low blood pressure risk
Key caution Temporary blood pressure rise Fainting and low blood pressure
Compounded version Available by prescription; not FDA-approved Not typically compounded

Now let's walk through the rows that matter most.

How PT-141 Works

PT-141 is a melanocortin receptor agonist. In plain terms, it switches on receptors in the brain linked to sexual motivation.

It was discovered by accident. Researchers studying a tanning peptide, Melanotan II, noticed it raised arousal. PT-141 was refined from that line of work.

Because it acts in the brain, it targets desire rather than blood flow. That's the key difference from drugs like sildenafil. Our PT-141 vs Viagra and Cialis guide explains that contrast in detail.

How Addyi Works: Mechanism of Action

Addyi works on serotonin, a brain chemical involved in mood and inhibition. It stimulates 5-HT1A receptors and blocks 5-HT2A receptors.

The working theory is a rebalancing act. Less serotonin "braking" may let dopamine and norepinephrine, which support desire, have more influence.

Addyi was originally developed as an antidepressant. It didn't succeed there, but researchers noticed effects on libido. That's why it's taken daily, like many mood-related medications. It needs weeks of steady use, not a single dose.

What the Research Shows

PT-141 in the RECONNECT trials

Vyleesi's approval rests on two phase 3 trials called RECONNECT. They enrolled 1,267 premenopausal women with HSDD.

In the published results, bremelanotide produced statistically significant gains in desire scores versus placebo. It also reduced distress about low desire.

The improvements were modest on average. Nausea, flushing and headache each affected 10% or more of users in both studies.

Addyi in pooled trials

A 2016 meta-analysis in JAMA Internal Medicine pooled eight studies with 5,914 women. On average, flibanserin added about one-half of a satisfying sexual event per month over placebo.

The same review found higher risks of dizziness, sleepiness, nausea and fatigue. The authors graded the overall evidence quality as very low.

What this means

Neither drug is a dramatic switch. Both show measurable but modest average effects. Some people respond well, and some don't respond at all.

That's why both labels advise stopping after about eight weeks if there's no improvement.

Does Addyi Work? Does PT-141?

"Does Addyi work?" is one of the most searched questions about it. The honest answer: for some people, a little. For others, not noticeably.

Average trial gains for both drugs were modest. Some users report a clear shift in interest. Many report minimal change. Online reviews tend to reflect those extremes.

A few factors shape the odds of a response:

  • The right diagnosis: both drugs were studied in acquired, generalized HSDD, not every kind of low desire.
  • Other causes addressed: untreated depression, pain or relationship strain can blunt any medication.
  • A fair trial: Addyi needs weeks of nightly use. PT-141 may need a few tries to judge.
  • Tolerability: side effects like nausea or dizziness lead some people to stop early.

Set realistic expectations before you start. These medications may nudge desire. They don't manufacture it on command.

Side Effects Compared

Concern PT-141 Addyi
Nausea Most common; often after the first dose Reported, less prominent
Flushing Common, usually short-lived Not a hallmark
Dizziness and sleepiness Less common Among the most common
Blood pressure Temporary rise after a dose Can drop, sometimes sharply
Skin changes Darkened patches reported with repeated use Not reported as typical

The pattern is telling. PT-141's side effects cluster around each dose. Addyi's are more about daily, ongoing exposure, especially around bedtime.

For a deeper look, see our breakdown of PT-141 side effects from clinical trials.

Alcohol: The Biggest Practical Difference

This is where the two drugs split most clearly in daily life.

Addyi carries a boxed warning about severe low blood pressure and fainting. Risk rises with alcohol, with certain drugs that block the liver enzyme CYP3A4, and with liver impairment.

The label sets alcohol timing rules. In short:

  • After one or two standard drinks, wait at least two hours before the bedtime dose.
  • After three or more drinks, skip that night's dose.
  • Don't drink after taking the bedtime dose.

PT-141 has no matching alcohol restriction on its label. That doesn't make heavy drinking a good idea. It just removes one daily calculation.

Dosing and Daily Routine

Think about how each would fit your actual life.

PT-141 suits people who prefer on-demand use. You plan ahead by about 45 minutes. There's nothing to take on days you're not intimate.

Addyi suits people who prefer a fixed routine. One pill, every night. No injection, but no days off either.

Some people find a needle a dealbreaker. Others dislike daily medication. Neither preference is wrong.

Curious whether PT-141 could fit your routine? Learn how PT-141 at TelosRX works. Any prescription is subject to medical approval by a licensed provider after an asynchronous review of your health history. Compounded PT-141 is not FDA-approved.

Who Should Be Cautious

Both medications need a careful medical history first. Common red flags include:

  • PT-141: uncontrolled high blood pressure or known heart disease.
  • Addyi: regular alcohol use, liver problems, or medications that interact through CYP3A4.
  • Both: pregnancy, plans to conceive, or symptoms that suggest another cause of low desire.

Low desire can stem from relationship stress, depression, hormones, pain or other medications. A good evaluation looks at those first.

What About Men?

Neither brand product is FDA-approved for men. Any use in men is off-label, meaning outside the approved indication.

Some small studies have explored bremelanotide in men, mostly for erectile function in earlier research. Evidence for flibanserin in men is very limited.

If you're a man interested in either, a provider should weigh the thin evidence against your history. Expect honest talk about uncertainty.

Brand Vyleesi vs Compounded PT-141

Vyleesi is the FDA-approved brand autoinjector. Compounded PT-141 contains bremelanotide but is prepared by a licensed pharmacy for an individual prescription.

Compounded versions are not FDA-approved. They haven't gone through the same review for safety, effectiveness or manufacturing. Some come as nasal sprays or different doses than the brand.

Our explainer on bremelanotide vs Vyleesi vs compounded PT-141 sorts out the naming.

PT-141 vs Addyi: Which to Consider?

There's no universal winner. The better fit depends on your health, habits and preferences.

If this sounds like you Option often discussed
You drink alcohol socially and don't want timing rules PT-141
You want something only for specific occasions PT-141
You strongly prefer a pill over any injection Addyi
You have uncontrolled high blood pressure Discuss carefully; PT-141 may not suit you
You take a CYP3A4-interacting medication Discuss carefully; Addyi may not suit you

Either way, track how you feel for about eight weeks. If nothing changes, it's reasonable to stop and revisit the plan with your provider.

Questions to Ask Your Provider

  1. Could something else be driving my low desire, such as hormones or medications?
  2. Does my blood pressure history rule out either option?
  3. How does my alcohol use affect the choice?
  4. What side effects should make me stop and check in?
  5. How will we judge whether it's working?

Women weighing options may also find our PT-141 for women guide useful.

Frequently Asked Questions

Is PT-141 better than Addyi?

Neither is clearly better for everyone. PT-141 is taken as needed and has no label alcohol restriction, but it requires an injection and often causes nausea. Addyi is a daily pill with alcohol timing rules and a fainting risk. Trial effects for both are modest. A licensed provider can help match an option to your history.

Can you take PT-141 and Addyi together?

Combining PT-141 and Addyi hasn't been studied in published clinical trials, so safety and benefit are unknown. They act on different brain pathways, and their side effects on blood pressure move in opposite directions. Don't combine them on your own. Any plan that involves both should come only from a prescriber reviewing your full history.

How fast does PT-141 work compared with Addyi?

Brand PT-141 is labeled for use about 45 minutes before anticipated sexual activity. Addyi works differently. It's taken nightly, and benefits, if any, build over several weeks. Both labels suggest stopping after about eight weeks if there's no improvement, so give either option a fair trial with your provider.

Can you drink alcohol with PT-141?

The Vyleesi label doesn't carry the alcohol restrictions found on Addyi. Still, alcohol can lower inhibitions, affect judgment and add to nausea. Moderate intake is the safer choice. Talk with your provider about your usual drinking habits, especially if you also take other medications that affect blood pressure.

Is Addyi or PT-141 approved for postmenopausal women?

No. In the US, both brand products are FDA-approved only for premenopausal women with acquired, generalized hypoactive sexual desire disorder. Use outside that group is off-label. Postmenopausal women with low desire should discuss the full range of options, including hormonal factors, with a licensed provider.

Is compounded PT-141 the same as Vyleesi?

They share the active ingredient, bremelanotide, but they aren't the same product. Vyleesi is an FDA-approved autoinjector. Compounded PT-141 is prepared by a licensed pharmacy for an individual prescription and is not FDA-approved. Doses and forms, such as nasal sprays, may differ from the brand.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX